Article info

PDF
Picket
Rituximab is more effective than tacrolimus in steroid-dependent nephrotic syndrome

Authors

  1. Correspondence to Dr Alex D Lalayiannis, Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK; alex.lalayiannis{at}nhs.net
View Full Text

Citation

Solomon N, Lalayiannis AD
Rituximab is more effective than tacrolimus in steroid-dependent nephrotic syndrome

Publication history

  • First published February 1, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.